Get started
Author

Naokatsu Nakada

Observed names: N. Naokatsu, NAOKATSU NAKADA
ORCID: 0000-0002-7243-1083
Observed ORCID: 0000-0002-7243-1083
OpenAlex ID: A5110734916
Prognosis of Immune-related Adverse Events in Patients With Advanced Gastric Cancer Treated With Nivolumab or Pembrolizumab: A Multicenter Retrospective Analysis
2021 · TAKAYUKI ANDO, AKIRA UEDA, et al. · In Vivo · 31
PDF
CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
2024 · Akira Ueda, Satoshi Yuki, et al. · Cancers · 11
Liver metastasis affects progression pattern during immune checkpoint inhibitors monotherapy in gastric cancer
2023 · Iori Motoo, Takayuki Ando, et al. · Frontiers in Oncology · 7
PDF
Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced Gastric Cancer
2022 · Takayuki Ando, Ayumu Hosokawa, et al. · Oncology · 5
[A case of a gastrointestinal stromal tumor of the rectum effectively treated with continuously-administered regorafenib after failure of imatinib and sunitinib].
2016 · Shinya Kajiura, Ayumu Hosokawa, et al. · PubMed · 5
The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal Metastasis
2024 · Yurika Nakayama, Takayuki Ando, et al. · Journal of Clinical Medicine · 4
PDF
Lesion-level response to immune checkpoint inhibitor in patients with advanced gastric cancer.
2022 · Iori Motoo, Takayuki Ando, et al. · Journal of Clinical Oncology · 2
Prognostic impact of immune-related adverse events with nivolumab in patients with advanced gastric cancer: A multicenter retrospective analysis.
2020 · Yuno Ohya, Takayuki Ando, et al. · Journal of Clinical Oncology · 2
412 Clinical factors associated with acute progression of metastatic tumors after resection of the primary tumor in patients with unresectable colorectal cancer
2015 · T. Ando, H. Ayumu, et al. · European Journal of Cancer · 2
CA125 kinetics as a potential biomarker of prognosis in nivolumab monotherapy for patients with advanced gastric cancer and peritoneal metastasis.
2023 · Takayuki Ando, Satoshi Yuki, et al. · Journal of Clinical Oncology · 1
CA125 kinetics as a potential biomarker for ascites progression during taxane plus ramucirumab therapy in patients with advanced gastric cancer.
2023 · Akira Ueda, Satoshi Yuki, et al. · Journal of Clinical Oncology · 1
PDF
MO5-1 Characteristics of immune-related adverse events in patients with advanced esophageal cancer treated with nivolumab
2021 · Naokatsu Nakada, Takayuki Ando, et al. · Annals of Oncology · 1
PDF
[A Case of Advanced Gastric Cancer with Severe Jaundice from Multiple Liver Metastases That Was Significantly Improved after Capecitabine plus Oxaliplatin Treatment].
2016 · Hiroaki Takagi, Takayuki Ando, et al. · PubMed · 1
Preventive effect of rikkunshito, traditional Japanese medicine, for chemotherapy-induced nausea and vomiting.
2012 · Shinya Kajiura, Ayumu Hosokawa, et al. · Journal of Clinical Oncology · 1
P57-3 Factors of the third-line treatment induction in advanced gastric cancer based on eligibility for clinical trials
2022 · Miho Sakumura, Takayuki Ando, et al. · Annals of Oncology
MO5-5 Lesion-level response to immune checkpoint inhibitor in patients with advanced gastric cancer and esophageal cancer
2021 · Iori Motoo, Takayuki Ando, et al. · Annals of Oncology
Works count: 16
Citation count: 74
H-index: 5
I10-index: 2
Year
Topic
Type